Veteran managers steer Baird Mid Cap Growth using a quality-oriented, time-tested approach. It earns a Morningstar Medalist Rating of Bronze across both share classes.
Baird Mid Cap Growth Institutional BMDIX
- NAV / 1-Day Return 25.84 / 0.00
- Total Assets 2.6 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.820%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 10,000
- Status Open
- TTM Yield —
- Turnover 42%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0
Morningstar’s Analysis BMDIX
Will BMDIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
IDEXX Laboratories Inc | 3.05 | 77.9 Mil | Healthcare |
Icon PLC | 2.87 | 73.5 Mil | Healthcare |
DexCom Inc | 2.71 | 69.2 Mil | Healthcare |
First American Government Obligs U | 2.68 | 68.6 Mil | Cash and Equivalents |
CDW Corp | 2.55 | 65.3 Mil | Technology |
Globant SA | 2.50 | 63.9 Mil | Technology |
Heico Corp | 2.47 | 63.0 Mil | Industrials |
Veeva Systems Inc Class A | 2.32 | 59.2 Mil | Healthcare |
Copart Inc | 2.13 | 54.5 Mil | Industrials |
Watsco Inc Class A | 2.13 | 54.4 Mil | Industrials |